The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

BACKGROUND: Obesity, type 2 diabetes mellitus (T2D) and unhealthy blood lipid profile are strongly associated with the risk of developing cardiovascular disease (CVD). We examined whether blood lipid changes with short term administration of the weight lowering drug, sibutramine and lifestyle modifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weeke, Peter, Andersson, Charlotte, Fosbøl, Emil L, Brendorp, Bente, Køber, Lars, Sharma, Arya M, Finer, Nick, James, Philip T, Caterson, Ian D, Rode, Richard A, Torp-Pedersen, Christian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848038/
https://www.ncbi.nlm.nih.gov/pubmed/20184783
http://dx.doi.org/10.1186/1472-6823-10-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848038/
https://www.ncbi.nlm.nih.gov/pubmed/20184783
http://dx.doi.org/10.1186/1472-6823-10-3

Ejemplares similares